Simplify complex datasets using Principal Component Analysis (PCA) in Python. Great for dimensionality reduction and ...

4D Molecular Therapeutics (FDMT) slipped ~15% on Wednesday after the company announced updated data from an early-stage trial for 4D-710, its experimental therapy for a genetic disorder known as ...

The system enables pixel-level alignment between shape and spectral data, allowing detailed visualization of traits like chlorophyll distribution across plant surfaces. Traditional plant phenotyping ...

The architecture, engineering, and construction (AEC) sector has always depended on visualization technology. From hand-drawn sketches to blueprints, to CAD models and photorealistic renderings, each ...

4D-150 demonstrated consistent and durable benefit across all three patient cohorts as evidenced by maintenance of visual acuity, control of retinal anatomy and reduction of treatment burden at all ...

Bubsy the Bobcat, star of the eponymous, oft-derided Bubsy series of hit-or-miss platforming games, is back in a new adventure called Bubsy 4D. Publisher Atari and developer Fabraz, known for the ...

(RTTNews) - Shares of 4D Molecular Therapeutics (FDMT) are up over 26% to $5.69 in premarket trading Friday, following positive 60-week data from its Phase II SPECTRA trial. The SPECTRA trial is ...

4D Molecular Therapeutics has posted 60-week data on a gene therapy, providing evidence of durability in diabetic macular edema (DME) and sending its stock up more than 40% in premarket trading. The ...

Based on the analysis, the advanced visualization systems market is expected to grow from USD 799 million in 2025 to USD 1.2 billion by 2035, at a CAGR of 4.6%. Increasing adoption of visualization ...